Case Report
Hepatic Metastasis From
Recurrent Ovarian Granulosa Cell Tumor:
A Rare Entity
Shaliq Navas1, Aanchal Bhayana2,
Neha Bagri3*, Ritu Misra4
Department of Radio-diagnosis, VMMC &
Safdarjung Hospital, New Delhi.
shaliqnavas@gmail.com1,
aanchalbhayana@gmail.com2,
drnehabagri@gmail.com3,
misraritu@gmail.com4
ABSTRACT
Granulosa cell tumour (GCT) is a rare sex cord-stromal
tumour of the ovary with a considerable propensity for late recurrences.
However, liver metastasis is extremely rare, with an incidence of 5-6%. We
present a case report of remote recurrence of GCT with liver metastasis in a
patient with a past surgical history for right ovarian GCT many years back. GCT
primarily has a low malignant potential, but it has a high tendency to recur
with metastasis, usually within the pelvis. Inhibin B and AMH are the most
accurate tumour markers for the detection of recurrent GCT. Ultrasound of the abdomen
revealed a complex solid cystic mass in the retroperitoneum and multiple
hepatic lesions, the biopsy from which revealed metastatic GCT. Henceforth, radiologists
and gynaecologists need to be aware of delayed and remote recurrence of ovarian
GCT with distant metastasis for appropriate management and follow-up of these
patients.
Keywords: Granulosa cell tumour, Ovary, Recurrence, Liver metastasis, Ultrasound
*Correspondence:
Dr Neha Bagri
drnehabagri@gmail.com
Ph no. 9013606279
INTRODUCTION
Granulosa cell tumour (GCT)
is a rare sex cord-stromal tumour of the ovary, which accounts for 2-5% of all
ovarian tumours.1 With a 25-30% incidence rate, GCT has a
considerable propensity for late recurrences.2 However, metastasis
of the liver is extremely rare, with an incidence of 5-6%.1 This
rare case report describes a patient who underwent surgery for ovarian GCT
eight years ago and then presented with retroperitoneal GCT and liver
metastasis.
CASE REPORT
A 49-year-old female was
admitted to the gynaecology department with pain in the abdomen associated with nausea. She had no
complaints of weight loss, vaginal bleeding, or lower abdominal pain. A
detailed history revealed a history of total abdominal hysterectomy with
bilateral salpingo-oopherectomy done for the right ovarian granulosa cell
tumour eight years back. Routine blood investigation (including CBC and LFT)
and tumour markers AFP, CA19-9, CA 125, CA 15-3, estradiol and AMH were within
normal limits. However, the serum inhibin B value was elevated.
After
these investigations, she was referred for an abdomen ultrasound, which
revealed a large, predominantly solid mass measuring approximately
13.5x11.8x7.2 cm in size in the left anterior pararenal space. The mass showed
a mild increase in vascularity. The left kidney was displaced posteriorly, and
the mass extended to the aortic bifurcation inferiorly. There was no vascular
or bowel invasion. There were three similar morphology, predominantly solid
masses with interspersed cystic areas in segments 2, 5 and 8 of the liver, the
largest measuring 7.1x3.9x2.7 cm. cm cm in size.
Figure 1a-b. US abdomen shows retroperitoneal and
hepatic masses. 1c. CECT abdomen shows a mass in the left anterior
pararenal space and multiple hepatic masses. 1d. Previous pelvic MRI (8
years back) showed similar morphology right ovarian mass.
There
was no apparent residual /recurrent mass in the pelvic region. The rest of the
abdominal organs were normal. Subsequently, a CECT abdomen was performed, which
confirmed the ultrasound findings and helped better delineate the fat planes
and extent of the retroperitoneal mass. The hepatic lesions showed moderate
progressive enhancement without any wash-out in the delayed phase.
The
patient underwent an ultrasound-guided biopsy of the most extensive hepatic
lesion, which revealed a metastatic granulosa cell tumour. The nuclei of the
tumour cells were grooved, giving the appearance of the classical coffee bean,
the characteristic features of GCT.
The Call Exner bodies were
seen within the microfollicular pattern of this tumour. On histochemistry, the
tumour was positive for inhibin, vimentin, calretinin, S-100, ER, PR and
focally positive for SMA. Considering the advanced and metastatic stage of the disease,
the patient was a non-surgical candidate, and chemotherapy was started and kept
on follow-up.
DISCUSSION
Granulosa cell tumour (GCT)
is a type of ovarian sex cord-stromal tumour which accounts for 2-5% of all
ovarian cancers. There are two types of GCT- adult type (90%) and juvenile type
(5%).1 In the adult type of GCT, patients usually present with
post-menopausal bleeding due to the prolonged exposure of the endometrium to
the tumour-derived estradiol. Abdominal pain is another joint presentation, as
the tumour is generally large and haemorrhagic. GCT usually has a low malignant
potential but a high tendency to recur, and metastasis is typically present
within the pelvis. Distant metastasis is very rare. Liver metastasis accounts
for no more than 5-6% of cases.2 Inhibin B and AMH are the most
accurate tumour markers for the detection of recurrent GCT.3
The
imaging reveals predominantly solid or complex solid-cystic mass, commonly
arising from the ovary, which can be confirmed on cross-sectional imaging.
Hepatic metastatic lesions also show similar morphology on imaging. They might
closely resemble a primary HCC, cystadenoma, complicated hepatic cysts, or
other liver metastases. 4 Hence, histopathology is needed for a
definite diagnosis of this entity.
In
the present case, the retroperitoneal recurrence of ovarian GCT, along with
hepatic metastasis, makes it an infrequent presentation and a key learning
point for radiologists and surgeons. Past surgical history and knowledge of
previous histopathology reports played a crucial role. Primary retroperitoneal
GCT are again very rare masses, and very few have been reported in the existing
literature. GCTs are known to be aggressive in case of recurrence, as seen in
the present case. This case highlights the importance of long-term follow-up of
ovarian GCT because more than 50% of recurrence occurs after five years.
CONCLUSION
In this case, the
retroperitoneal recurrence of ovarian GCT and hepatic metastasis emphasises the
gravity of long-term follow-up. Inhibin B and AMH are the most accurate tumour
markers for recurrent detection. The key message is that remote recurrence with
hepatic metastasis can be a rare, aggressive presentation of ovarian GCT that
has been treated long ago. Hence, radiologists and surgeons must know this
entity and follow up on these patients.
Acknowledgement: Thankful to all the contributors
Conflicts of interest: None
Source(s) of support: Nil
Contributor’s detail: All authors contributed
equally to this work
REFERENCES
1.
Schumer ST,
Cannistra SA. Granulosa cell tumor of the ovary. J Clin Oncol. 2003 Mar
15;21(6):1180-9. doi: 10.1200/JCO.2003.10.019. PMID:
12637488.
2.
Yu S, Zhou X, Hou
B, Tang B, Hu J, He S. Metastasis of the liver with a granulosa cell tumor of
the ovary: A case report. Oncol Lett 9: 816-818, 2015.
3.
Aleter A, Mahajan PS, Petkar MA,
Abdulmajeed HA, Khalaf H, Elmoghazy W, Elaffandi A. Late Cystic Metastasis of an Ovarian Granulosa
Cell Tumor to the Liver. Cureus. 2021 Sep 17;13(9): e18051.
4.
Neste MG, Francis
IR, Bude OR. Hepatic metastasis from granulosa cell tumor of the ovary: CT and
sonographic findings. AJR 1996; 166:1122-24.